Drug Development in Dementia

Dementia is a progressive, irreversible decline in cognition that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementia has several aetiologias of which Alzheimer’s disease (AD) is the most common. Drug development in AD is based on evolving pathophysiological theory. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signaling, neuroinflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and on-going promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.

    Related Conference of Drug Development in Dementia

    November 25-26, 2024

    19th Annual Congress on Neuroscience

    Paris, France
    November 26-27, 2024

    4th Annual Dementia Congress

    Paris, France
    December 05-06, 2024

    7th World Congress on Epilepsy and Brain Disorders

    Dubai, UAE
    December 05-06, 2024

    9th Annual Congress on Pediatric Neurology and Pediatric Surgery

    Prague, Czech Republic
    December 11-12, 2024

    9th World Congress on Spine and Spinal Disorders

    Paris, France
    December 12-13, 2024

    36th World Congress on Neurorehabilitation

    London, UK
    December 12-13, 2024

    38th European Neurology Congress

    Rome, Italy
    February 03-04, 2025

    37th World Conference on Neurology

    London, UK
    February 17-18, 2025

    5th International Conference on Child Neurology

    Aix-en-Provence, France
    February 20-21, 2025

    6th International Conference on Neurologists

    Amsterdam, Netherlands
    February 24-25, 2025

    4th International Conference onAlzheimer and Dementia

    Madrid, Spain
    February 27-28, 2025

    7th World Depression Congress

    Paris, France
    March 10-11, 2025

    8th World Conference on Neuroscience

    Paris, France
    March 13-14, 2025

    7th World Conference on Neuroscience

    Prague, Czech Republic
    March 24-25, 2025

    38th European Neurology Congress 2025

    London, UK
    April 24-25, 2025

    6th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    April 29-30, 2025

    11th International Conference on Epilepsy & Treatment

    Barcelona, Spain
    July 17-18, 2025

    31st Annual Summit on Neuroscience & Neurological Disorders

    Amsterdam, Netherlands
    July 17-18, 2025

    35th World Congress on Neurology and Neuroscience

    Aix-en-Provence, France
    July 23-24, 2025

    15th Global Alzheimers Summit

    Paris, France

    Drug Development in Dementia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in